FDA Warning, Not Tariffs, Stop Canadian Supplement Firm 'Drug' Exports To US
This article was originally published in The Rose Sheet
Bill Beauty and Health Products, provider of the Bill Natural Sources supplements line and of contract manufacturing for other supplement marketers, informed FDA that it won't ship to the US its supplements that an agency inspection showed are not up to drug specs.
You may also be interested in...
NPA sounds alarm on Trump administration tariffs on $200bn in Chinese goods scheduled for October. In letter US Trade Representative, NPA President and CEO Daniel Fabricant asks the agency to exempt 57 items from the Harmonized Tariff Schedule that would impact hundreds of dietary ingredients.
Perrigo is latest consumer health firm to note substantially slower flu rates slammed OTC drug sales during 2020 fourth quarter. Its total cough/cold product sales for the year were off $63m on decreases of $34m in the Americas and $29m in its international markets.
In deal with Altaris Capital, “I don't feel like we got out at any cost,” says Perrigo CEO Murray Kessler. Agreement calls for “a number of mutual long-term relationship components ... including on Rx-to-OTC switches."